What's new
This page lists items that we have published for the first time or updated in the last 7, 30 or 60 days. Use the filters to narrow results by audience, product type, content type or topic.
You can also stay informed by:
- subscribing to our updates to receive same-day notification emails on safety information, scheduling updates or media releases.
- checking our consultation hub.
- joining any upcoming events.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (7)
- Breast implant hub (1)
- Committees and advisory bodies (1)
- Compliance and enforcement (12)
- Fees and payments (2)
- Import and export (2)
- Labelling and packaging (8)
- Legislation (17)
- Manufacturing (3)
- Metal-on-metal hip replacement implants hub (1)
- Peptide products (1)
- Safety monitoring and information (12)
- Scheduling (national classification system) (7)
- Shortages and supply disruptions (8)
- Sunscreens (2)
- Unique Device Identification (UDI) hub (6)
- Urogynaecological (transvaginal) surgical mesh hub (1)
- Vaping hub (1)
What's new
114 result(s) found, displaying 101 to 114
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulation 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations).
-
DatasetSearch registrations for new medicines including generic medicines, chemical and biological entities (NCE and NBE), biosimilar medicines, biologicals and combinations. This includes extensions of indications, which describes new uses of medicines.
-
-
PageA substitution with dapsone 50 mg tablets has been approved for use during the shortage.
-
User guideInstalling the ADR reporting template in the Medical Director software.
-
User guideUsing the ADR reporting template in the Medical Director software
-
PageWe’re transforming the way you interact with us by building a modern, intuitive digital platform that aims to make interactions with us easy, seamless and efficient.
-
TopicFind out how peptide products are regulated in Australia, the risks of buying unapproved products online and the rules for importing, supplying, manufacturing or advertising them.
-
PageLearn how feedback from the Beta release is shaping improvements to TGA Business Services.
-
GuidanceGuidance for sponsors on the fees payable and timeframes for different types of prescription medicine applications.
-
PagePrepare for TGA Business Services (TBS) moving into the Health Business Services (HBS) portal. Know what's changing and how to get ready.
-
ChecklistsThese checklist summarises key obligations for psychiatrists applying to prescribe and access MDMA and psilocybine under the Authorised Prescriber scheme.
-
News articlesAndrographis paniculata (Andrographis) has been removed from the ingredients allowed in new listed medicines intended for supply in Australia from 17 September 2026.
-
DatasetSearch applications for new medicines, or new uses for existing medicines, that are under current evaluation.